Fennec Pharmaceuticals is seeking experienced oncology professionals to help support the fight against cisplatin-induced ototoxicity. Do you want to work for a small but powerful company? Send us your resume if you're ready to roll up your sleeves and work hard for an important cause. We are currently hiring Strategic Account Managers and Medical Science Liaisons. To apply, please visit https://lnkd.in/ekqzxkTF #AccountManager #Hiring #Oncology #SmallCompany #Pharmaceuticals
Fennec Pharmaceuticals Inc
制药业
Fiercely devoted to the fight against ototoxicity in pediatric cancer patients who receive cisplatin-based chemotherapy.
关于我们
Fiercely dedicated to the fight against cisplatin-induced ototoxicity. www.fennecpharma.com
- 网站
-
https://www.fennecpharma.com/
Fennec Pharmaceuticals Inc的外部链接
- 所属行业
- 制药业
- 规模
- 11-50 人
- 总部
- Research Triangle Park
- 类型
- 上市公司
- 创立
- 1996
地点
-
US,Research Triangle Park,27709
Fennec Pharmaceuticals Inc员工
-
Pierre Sayad, PhD, M.S.
Chief Medical Officer @ Fennec Pharmaceuticals | 'Commercially-Minded' Scientist Strategist
-
Christopher DePinto
Head of Sales, Fennec Pharmaceuticals
-
Shaunna Cornett
15+ Years of Marketing Operations experience
-
Mary Beth Collins
Director of Programs, National Association for Children of Addiction
动态
-
We’re excited to be attending the American Academy of Audiology Annual Meeting in New Orleans! Visit us at booth #601 to learn more about our commitment to protecting patients with cancer against the profound threat of cisplatin-induced ototoxicity. #AAA2025 #AudiologyCare #HealthyHearing
-
-
Cisplatin remains a cornerstone in the treatment of various cancers, yet its potential to cause irreversible hearing loss, or cisplatin-induced ototoxicity (CIO), is a critical concern, and routine audiometric monitoring is not always integrated into care. Healthcare professionals play a key role in ensuring that patients receive comprehensive care that includes hearing preservation strategies. Collaborative efforts between oncologists, audiologists, and researchers are vital to preventing ototoxicity during treatment with platinum-based chemotherapies. ? By prioritizing hearing health as a standard component of chemotherapy management, we can prevent CIO to improve patient outcomes and quality of life. #OncologySupport #CisplatinOtotoxicity #HearingHealth #CancerTreatment #ChemoSideEffects
-
-
In late February, the Fennec team got together in-person for an inspirational and unforgettable National Meeting. This was a time for our team to celebrate all of the great progress that we are making collectively in preventing cisplatin-induced ototoxicity (CIO), or permanent hearing loss, and align on our vision for the future of this product and our Company. We also took some time to collaborate with Tampa General Hospital to make blankets and collect gifts for local kids with cancer who are going through treatment at the hospital. Thank you to our team for continuing to share in the important work that we are doing to increase awareness among patients and oncologists surrounding the importance of preventing CIO. #NationalMeeting #RisingTide #StrongerTogether #Leadership
-
-
Today is #WorldHearingDay, a moment to come together and raise awareness around preventing deafness and hearing loss across the world. For survivors of cancer, cisplatin-induced ototoxicity (CIO) – or permanent hearing loss – impacts many crucial aspects of life, such as speech/language skills, academic performance, mental health and even employment. At Fennec, we are focused on addressing unmet patient needs and changing the standard of care for CIO prevention. Join us in raising awareness around the importance of preventing CIO for cancer patients, and promoting ear and #hearingcare across the world.
-
Cisplatin-induced ototoxicity, or permanent hearing loss, comes with a life-long impact for survivors of #cancer. Learn more from patients and families who have been impacted by this devastating side effect of treatment: https://lnkd.in/eHm2b93x #ChemoSideEffects #CancerSupport #CancerSurvivor
-
-
Our CEO,?Jeff Hackman, shared his perspective on therapeutic area advancements in 2025 as part of Scrip’s annual forward-looking series for the biotechnology industry.? ? His thoughts on prioritizing considerations around #cancer treatment side effects are in line with a trend we’ve seen across the board from #oncologists and healthcare professionals to place people at the center of cancer care to fully integrate each individual’s unique needs - ensuring that patients not only survive cancer but also thrive post-treatment.? ? Learn more: https://lnkd.in/dSyX8Mmu
-
-
Just one treatment cycle of platinum-based chemotherapy can lead to a lifetime of hearing loss. Jake is one of thousands of patients who now relies on hearing aids following his battle with #cancer – but they do not restore normal hearing, and can make hearing even more difficult in noisy environments. Learn more about the impact of cisplatin-induced hearing loss:? https://lnkd.in/gExEpJ64 #ChemoSideEffects #HearingLoss #CancerAwareness
-
With overall survival rates of all cancers better than in previous decades, there is an increased importance on managing side effects of treatment, such as hearing loss from platinum-based #chemotherapy. Learn more about this common side effect: https://lnkd.in/gExEpJ64 #ChemoSideEffects #HearingLoss #CancerAwareness
-
-
On International Childhood Cancer Day, we stand with patients like Ella and their families to raise awareness of the challenges faced by childhood #cancer patients, including serious side effects from chemotherapy such as #ototoxicity, or permanent hearing loss. #ICCD2025